Abstract
The American Joint Committee on Cancer staging system suggests that squamous-cell carcinoma of the oral cavity (OSCC) with pN2 should be classified as stage IVA. The objective of the current study was to determine the outcome of patients with pN2 OSCC cancer according to different T status. Between January 1996 and September 2007, a total of 270 patients with pN2 OSCC cancer were analyzed. All participants had a follow-up of at least 2 years or were censored on the date of last follow-up. The outcome measures for this study were the 5-year rates of locoregional control, distant metastases, and survival. Five-year disease-specific survival and overall survival rates in pT1 (n = 9), pT2 (n = 98), pT3 (n = 70), and pT4 (n = 93) patients were 78%, 66%, 49%, 35% (P = 0.0031), and 78%, 52%, 35%, 23% (P = 0.0001), respectively. Multivariable analysis revealed that pT3-4, level IV/V metastases, extracapsular spread, and poor differentiation were independent risk factors for 5-year disease-specific survival in the entire study cohort. Specific independent prognostic factors for 5-year disease-specific survival according to T stage were found. The results of this study suggest that patients with pN2 OSCC cancer have different outcomes an...Continue Reading
References
Dec 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J M BachaudN Daly-Schveitzer
Dec 5, 1997·The Annals of Thoracic Surgery·T De GiacomoC Ricci
Jun 3, 1998·São Paulo Medical Journal = Revista Paulista De Medicina·E F MurtaS Bighetti
Apr 5, 2000·Head & Neck·L P KowalskiJ Magrin
Jul 13, 2002·Cancer·Hung-Ming WangTung-Chieh Joseph Chang
Jan 3, 2003·Oral Oncology·J A WoolgarE D Vaughan
May 7, 2004·The New England Journal of Medicine·Jay S CooperUNKNOWN Radiation Therapy Oncology Group 9501/Intergroup
May 7, 2004·The New England Journal of Medicine·Jacques BernierUNKNOWN European Organization for Research and Treatment of Cancer Trial 22931
Sep 10, 2005·Oral Oncology·Julia A Woolgar
Sep 15, 2005·Head & Neck·Jacques BernierJ L Lefèbvre
Jun 14, 2006·Cancer·Chun-Ta LiaoTzu-Chen Yen
Jul 25, 2006·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Paolo Garzino-DemoMarina Schena
Sep 26, 2006·Oral Oncology·Chun-Ta LiaoTzu-Chen Yen
Jun 20, 2007·Cancer·Chun-Ta LiaoTzu-Chen Yen
Sep 18, 2007·Cancer·Chun-Ta LiaoTzu-Chen Yen
Jan 1, 2008·Annals of Surgical Oncology·Chun-Ta LiaoTzu-Chen Yen
Aug 5, 2008·Oral Oncology·Simon N RogersDavid Vaughan
Aug 20, 2009·Cancer·Ziv GilSnehal G Patel
Citations
Aug 7, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Chung-Guei HuangTzu-Chen Yen
Jun 1, 2011·ORL; Journal for Oto-rhino-laryngology and Its Related Specialties·Danielle Resende CamisascaSimone de Queiroz Chaves Lourenço
Jul 23, 2014·PloS One·Shih-Chi PengTzu-Chen Yen
Jan 25, 2012·Annals of Surgical Oncology·Fan-Yu MengTseng-Cheng Chen
Jun 25, 2013·The British Journal of Oral & Maxillofacial Surgery·Tommaso CutilliEmma Altobelli
May 9, 2012·Oral Oncology·Matthias KreppelMartin Scheer
Aug 16, 2011·Oral Oncology·Chung-Jan KangTzu-Chen Yen
Apr 3, 2014·Cancer·Ardalan EbrahimiUNKNOWN International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
Oct 12, 2010·International Journal of Radiation Oncology, Biology, Physics·Chun-Ta LiaoTzu-Chen Yen
Oct 10, 2012·Oral Oncology·Divya Khosla, Budhi Singh Yadav
Nov 28, 2012·Oral Oncology·Matthias Kreppel, Martin Scheer
Feb 2, 2019·Head & Neck·Takumi HasegawaUNKNOWN Japan Oral Oncology Group (JOOG)
Jan 21, 2020·Oral Diseases·Yung-Ding BowRuei-Nian Li
Mar 5, 2016·Medicine·Chun-Ta LiaoTzu-Chen Yen
Aug 26, 2020·PloS One·Nan-Chin LinKuo-Yang Tsai
Jul 26, 2016·Oncology Letters·Tommaso CutilliEmma Altobelli
Jun 4, 2017·Annals of Surgical Oncology·Chun-Ta LiaoTzu-Chen Yen
Jun 4, 2016·Medicine·Wen-Cheng ChenMiao-Fen Chen
Oct 7, 2020·Head & Neck·Indu ArunPattatheyil Arun
Jun 6, 2021·The Laryngoscope·Tsung-You TsaiKai-Ping Chang
Jun 27, 2021·Oral Oncology·Chung-Jan KangChun-Ta Liao
Sep 18, 2021·Cancer Medicine·Li-Yu LeeChun-Ta Liao
Sep 25, 2021·Cancer Medicine·Chien-Yu LinChun-Ta Liao